 Connection
Craig Friesen to Inflammatory Bowel Diseases
This is a "connection" page, showing publications Craig Friesen has written about Inflammatory Bowel Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.861 |
|
|
|
-
Hijaz NM, Attard TM, Colombo JM, Mardis NJ, Friesen CA. Comparison of the use of wireless capsule endoscopy with magnetic resonance enterography in children with inflammatory bowel disease. World J Gastroenterol. 2019 Jul 28; 25(28):3808-3822.
Score: 0.649
-
Turner D, Friesen C. Authors' response. J Pediatr Gastroenterol Nutr. 2013 Oct; 57(4):e25-6.
Score: 0.434
-
Turner D, Wolters VM, Russell RK, Shakhnovich V, Muise AM, Ledder O, Ngan B, Friesen C. Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel disease. J Pediatr Gastroenterol Nutr. 2013 May; 56(5):492-7.
Score: 0.421
-
Friesen CA, Calabro C, Christenson K, Carpenter E, Welchert E, Daniel JF, Haslag S, Roberts CC. Safety of infliximab treatment in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2004 Sep; 39(3):265-9.
Score: 0.231
-
Bass JA, Friesen CA, Deacy AD, Neilan NA, Bracken JM, Shakhnovich V, Singh V. Investigation of potential early Histologic markers of pediatric inflammatory bowel disease. BMC Gastroenterol. 2015 Oct 13; 15:129.
Score: 0.125
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|